In recent years, the process of biopsy testing has undergone a major transformation thanks to the development of artificial intelligence technology. The company imagene, founded in 2020 by three young developers – Dean Bitan, Yonatan Salah and Shahar Porat, has been at the forefront of this innovation. This Tel Aviv start-up has developed an AI system that can identify countless cancerous tumor characteristics within minutes, allowing doctors to quickly and accurately determine the best course of treatment for their patients.
At the Sheba Medical Center, this new technology has been implemented and is already being used in the first phase to analyze cancerous tumors. Prof. Iris Brashak, director of the pathology laboratory at Sheba and chairman of the Israeli Pathology Association, explains how this technology has revolutionized their work: “Since we switched to digital scanning of biopsies, we can view samples even from home and from anywhere in the world. The digital scan allows us to give quick answers to patients even when we’re not in the lab and consult with experts all over the world.”
The computers in the pathology lab now work overtime as they scan thousands of algorithms to identify tumor characteristics and mutations. Within a few minutes, they provide an initial diagnosis that allows medical teams to know what treatment options are available for their patients. This technology has already saved lives at Sheba Medical Center as it eliminates waiting times for genetic sequencing and other tests that were previously required before making a diagnosis.